申请人:Schering Aktiengesellschaft
公开号:US04364951A1
公开(公告)日:1982-12-21
Prostane derivatives of the formula ##STR1## wherein B is straight-chain or branched alkylene of 1-10 carbon atoms, A is --CH.sub.2 --CH.sub.2 --, trans--CH.dbd.CH--, or --C.tbd.C--; W is hydroxymethylene or a ##STR2## wherein the OH-group can be in the .alpha.- or .beta.-position, and is optionally modified by replacement of the H atom with an ether or acyl group which is conventional for such replacements in prostaglandins and which is readily cleavable at physiological pH's; D and E together are a direct bond or D is straight-chain or branched alkylene of 1-10 carbon atoms, or, such an alkylene of 4-10 carbon atoms containing a double bond in the 2- or 3- position, all of which can optionally be substituted by fluorine, 1,2-methylene, 1,1-trimethylene, or methoxy; E is oxygen, sulfur, --C.tbd.C-- or a direct bond; R.sub.2 is C.sub.1-10, C.sub.2-10 alkenyl, each of which optionally is substituted phenyl, 1-naphthyl or 2-naphthyl, each of which is substituted as defined below; C.sub.4-10 cycloalkyl optionally substituted by C.sub.1-4 alkyl; phenyl, 1-naphthyl, or 2-naphthyl, each of which can optionally be substituted by 1-3 halogen atoms, a phenyl group, 1-3 alkyl groups each independently of 1-4 carbon atoms, or a chloromethyl, fluoromethyl, trifluoromethyl, carboxy, C.sub.1 -C.sub.4 -alkoxy, or hydroxy group, or an aromatic 5- or 6-membered heterocyclic ring having one hetero ring atom which is O, N, or S, the remaining atoms being carbon; and R.sub.1 is hydroxy optionally modified as for W above, have valuable vasodilating, anti-hypertensive, and bronchodilating pharmacological properties.
公式为 ##STR1## 的prostane衍生物,其中B是1-10个碳原子的直链或支链烷基,A是--CH.sub.2 --CH.sub.2 --,trans--CH.dbd.CH--或--C.tbd.C--;W是羟甲基或 ##STR2## 其中OH基团可以在α或β位置,且可以通过取代H原子以ether或acyl基团进行修改,这在prostaglandins中是常规的,并且在生理pH下容易被裂解;D和E一起是直接键,或者D是1-10个碳原子的直链或支链烷基,或者是含有2-或3-位置双键的4-10个碳原子的烷基,所有这些都可以选择性地被氟、1,2-亚甲基、1,1-三亚甲基或甲氧基取代;E是氧、硫、--C.tbd.C--或直接键;R.sub.2是C.sub.1-10、C.sub.2-10烯基,每个烯基可以选择性地被取代为苯基、1-萘基或2-萘基,每个取代如下所定义;C.sub.4-10环烷基可以选择性地被C.sub.1-4烷基取代;苯基、1-萘基或2-萘基,每个可以选择性地被1-3个卤素原子、苯基、1-3个独立的碳原子为1-4的烷基取代,或者是氯甲基、氟甲基、三氟甲基、羧基、C.sub.1-C.sub.4-烷氧基或羟基,或者是具有一个杂环原子的芳香5-或6-成员环,该杂环原子是O、N或S,其余原子是碳;R.sub.1是羟基,可以选择性地按照上述W进行修改,具有有价值的扩血管、降压和支气管扩张药理学特性。